PO

Pierre Olivier Goineau

Europe, Rhone-Alpes, France, Lyon

Description

Pierre Olivier Goineau - President @ Neuronax

Investor Profile

Pierre Olivier Goineau has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown rounds (top funding stages).
  • Majority of deals are located in France.
  • Strong thematic focus on Biopharma, Biotechnology, Health Care.

Stage Focus

  • Series Unknown (100%)

Country Focus

  • France (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Health Care
  • Medical
  • Medical Device
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Pierre Olivier Goineau frequently co-invest with?

IRDI
Europe, Midi-Pyrenees, France, Toulouse
Co-Investments: 1
Principia SGR
Europe, Lombardia, Italy, Milan
Co-Investments: 1
Sofimac Investment Managers
Europe, Auvergne, France, Clermont-ferrand
Co-Investments: 1
IXO Private Equity
Europe, Midi-Pyrenees, France, Toulouse
Co-Investments: 1

What are some of recent deals done by Pierre Olivier Goineau?

Ixaltis

Toulouse, Midi-Pyrenees, France

Ixaltis is a pharmaceutical company that develops therapeutics to treat genitourinary disorders with unsatisfied medical needs.

BiopharmaBiotechnologyHealth CareMedicalMedical DevicePharmaceuticalTherapeutics
Series UnknownMay 31, 2016
Amount Raised: $8,000,000